Centrus Energy Corp.Centrus signed a HALEU supply agreement with Oklo and has a $3.9B backlog, indicating strong end-customer demand.
Centrus Energy shares have fallen about 63% from their all-time high of $464.25 in October 2025, creating a potential buying opportunity for long-term investors. The company is the only U.S.-licensed producer of high-assay, low-enriched uranium, or HALEU, which is essential for next-generation nuclear reactors and has a market opportunity that could reach $8 billion annually by 2035. Centrus reported mixed first-quarter results with GAAP earnings per share of $0.45 missing estimates, but non-GAAP adjusted earnings per share of $1.05 beat consensus, and management raised full-year revenue guidance to between $450 million and $500 million. The company holds a $3.9 billion order backlog extending through 2040 and operates under a Department of Energy HALEU contract worth up to $900 million, de-risking its expansion. On June 19, Centrus signed an agreement to supply HALEU to Oklo for up to five Aurora powerhouses in Southern Ohio, with deliveries starting in 2029.
Centrus Energy Corp.Centrus signed a HALEU supply agreement with Oklo and has a $3.9B backlog, indicating strong end-customer demand.
Oklo Inc.Oklo secured a HALEU supply agreement with Centrus for up to five Aurora powerhouses.